KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Total Debt (2016 - 2025)

Historic Total Debt for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $42.5 billion.

  • Eli Lilly's Total Debt rose 3659.06% to $42.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $42.5 billion, marking a year-over-year increase of 3659.06%. This contributed to the annual value of $33.6 billion for FY2024, which is 3337.48% up from last year.
  • As of Q3 2025, Eli Lilly's Total Debt stood at $42.5 billion, which was up 3659.06% from $39.9 billion recorded in Q2 2025.
  • Over the past 5 years, Eli Lilly's Total Debt peaked at $42.5 billion during Q3 2025, and registered a low of $15.9 billion during Q3 2022.
  • Over the past 5 years, Eli Lilly's median Total Debt value was $18.9 billion (recorded in 2023), while the average stood at $24.0 billion.
  • Per our database at Business Quant, Eli Lilly's Total Debt plummeted by 700.6% in 2022 and then skyrocketed by 5534.16% in 2023.
  • Quarter analysis of 5 years shows Eli Lilly's Total Debt stood at $16.9 billion in 2021, then decreased by 3.83% to $16.2 billion in 2022, then skyrocketed by 55.34% to $25.2 billion in 2023, then soared by 33.37% to $33.6 billion in 2024, then rose by 26.34% to $42.5 billion in 2025.
  • Its last three reported values are $42.5 billion in Q3 2025, $39.9 billion for Q2 2025, and $38.5 billion during Q1 2025.